Novartis reports US label changes for Clozaril

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1085, 2006-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Janssen, L.P., have issued a `Dear Health Care Professional' letter informing of changes to the US Duragesic [fentanyl transdermal system] label.

Reactions Weekly, Vol. 1, Iss. 1060, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The allergic asthma drug omalizumab [`Xolair'; Genentech/Novartis] is expected to cost an average $US10 000 annually when it is launched

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 418, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Black box warning added to US Dryvax label

Reactions Weekly, Vol. 1, Iss. 1029, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

US Prezista label: hepatotoxicity warning added

Reactions Weekly, Vol. 1, Iss. 1194-1195, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Rising off-label use of antipsychotics a concern in the US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 621, 2011-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite